# Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma

> **NCT00003423** · PHASE3 · UNKNOWN · sponsor: **United Kingdom Children's Cancer Study Group** · enrollment: 100 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** asparaginase
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** daunorubicin hydrochloride
- **DRUG:** dexamethasone
- **DRUG:** etoposide
- **DRUG:** mercaptopurine
- **DRUG:** methotrexate
- **DRUG:** prednisolone
- **DRUG:** thioguanine
- **DRUG:** vincristine sulfate

## Key facts

- **NCT ID:** NCT00003423
- **Lead sponsor:** United Kingdom Children's Cancer Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1995-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003423, "Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00003423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*